Chloroaluminium sulphonate phthalocyanine

Drug Profile

Chloroaluminium sulphonate phthalocyanine

Alternative Names: Chloroaluminum sulfonated phthalocyanine

Latest Information Update: 23 Nov 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Novartis
  • Class Antineoplastics; Phthalocyanines
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Bladder cancer

Most Recent Events

  • 23 Nov 2001 Profile reviewed but no significant changes made
  • 28 Oct 1997 No-Development-Reported for Bladder cancer in Switzerland (Unknown route)
  • 06 Oct 1995 Chloroaluminum sulfonated phthalocyanine is now called chloroaluminium sulphonate phthalocyanine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top